In conclusion, our results suggest that MCs may contribute to lung cancer-related thrombosis through the release of cytokines, including IL-13, SerpinE1, and Thrombopoietin, following the uptake of lung cancer cell-derived exosomes. The gene discussed is IL13; the disease is lung carcinoma.